Master Cases in ICSR Management

by

This blog covers:

  1. Understanding the definition of a master case
  2. Guidelines for choosing master cases with diagram
  3. Effective practices for managing duplicates by choosing a master case

Master Case: An Overview

Duplicate cases are typically managed by merging two or more cases into a single Master Case.

A Master Case is chosen from existing or creating a new case following identification of duplicates, to merge all relevant information is consolidated. This merging process is essential for maintaining accuracy and efficiency.

Choosing or Creating a Master Case

Before concluding whether choosing or creating a Master Case, first it must be validated as what is the best approach suits your case.

The process can follow one of these approaches:

  • Allotting an Existing Case: The Master Case can be one of the existing cases. Relevant information from the duplicate cases is added unless it is already present or a more precise version exists in the selected Master Case.
  • Creating a New Case: A new Master Case can be a new one, combining all relevant information from the duplicate cases into a single, comprehensive record.
📢 Recommendations: Here where we discusses multiple times about duplicates, first you need to know what are actually duplicates in ICSR reports, and strategies to identifying duplicates.

“Managing duplicates ensures clarity, accuracy, and the integrity of your data.”

Allocation of a Master Case

  • Allocating a master case involves designating one of the confirmed duplicate cases as the master case, which retains its status as a valid case.
  • The other (duplicate cases) should remain in the database, labeled as “invalidated/inactivated.” These cases are preserved for audit purposes but will not be reused for any future pharmacovigilance activities.
  • The selection of the master case can be based on several factors, including the case received first, the case containing the most detailed information, or the case that has already been transmitted to external partners.
  • If no significant new information is added to the master case, no submission is required for it.

Creation of a Master Case

  • When creating a master case, it is essential to document the case identifiers and the sources of the duplicate cases in the ICH-E2B(R2) data field, ensuring all relevant information from the subordinate duplicate cases is captured.
  • The subordinate duplicate cases should remain intact, linked to the newly created master case, until they are fully reviewed and any new follow-ups are received.
  • During this process, only the master case proceeds with further case processing with any coming subsequent follow-ups.
📢 Recommendation; The above diagram ended with mixing up the process called merging these cases, are you excited to learn more merging a process in ICSR handling.

Handling Follow-Up Reports

When follow-up (FU) information is received for any duplicate cases, the master case must be updated accordingly:

  • Evaluate and incorporate the follow-up information from any subordinate duplicate cases into the master case unless the same or more precise information is already present in the master case.
  • For allocated master cases, maintain the worldwide unique case identification number (ICH-E2B(R2) data field) in the master case for any follow-ups.
  • For created master cases, subordinate duplicates should be updated automatically based on new ICSRs. All newly received information must be evaluated, and the master case updated manually to ensure accuracy.
📢 Recommendation: Still uncertain? check out, What are reports mean by initial and follow-ups.

Best Practices for Handling Master Cases

  • Perform regular duplicate screenings to identify potential duplicates.
  • Validate and confirm duplicate cases.
  • Document cases that are confirmed as non-duplicates.
  • Monitor submission intervals and track submission times.
  • Allocate or create master cases strategically and accurately.
  • Inactivate or invalidate subordinate duplicates after processing.
  • Validate the significance of each master case thoroughly.
  • Archive invalidated or inactivated cases systematically for audits.
  • Expedite the submission of master cases to EDI partners as quickly as possible.

How can we assist you in case management?

Overwhelmed by a workflow clogged with duplicates and the hassle of managing them? Take a smart step forward—reach out to us for a solution! Don’t let your workflow stay overloaded while you wait and wonder.

Key Takeaways

The master case should facilitate all pharmacovigilance activities, including signal detection and medical review of ICSRs.

The creation of a master case must comply with ICH-E2B(R2) data field requirements.

Every master case should reference all case identifiers from subordinate duplicates for easy tracking.

All relevant information, including data from subordinate cases, must be included unless it is redundant in the master case.

Even if reporter details differ for identical cases, they may still be considered duplicates.

Conclusion

This comprehensive guide offers detailed insights into effectively managing duplicate cases and handling master cases. It clarifies the concept of a master case, how to choose one, and the essential steps to follow during the process.

If you find any inaccuracies or feel we’ve missed critical details, please share your feedback. Your constructive criticism helps us improve and refine our content.

Feel free to share this valuable resource with your colleagues and friends to promote better practices in duplicate case management.

Reference:
  1. Guideline on good pharmacovigilance practices (GVP) – Module VI Addendum I – Duplicate management of suspected adverse reaction reports.

Disclaimer: We write this blog based on our experience and extensive knowledge, supported by references. Please note that we are not responsible for the content on the referenced websites. If you come across any misinformation or misguidance or spelling mistakes, kindly inform us promptly.



Bala Avatar

Meet Bala, the founder of Drugvigil, a service provider specializing in pharmacovigilance. He’s not only an expert in this field, but also a passionate entrepreneur who enjoys creating new opportunities and helping others grow. Despite starting from scratch, he’s determined to develop his company from the ground up. If you’re interested in his work, be sure to show your support and share his message with others.




Just a fancy image. www.drugvigil.com






Comments

One response to “Master Cases in ICSR Management”

  1. […] So what is master case? You definitely have this on your mind. To learn more in detail check out our blog explaining about master case in merging process. 📢 Recommendation: Hey! I recommend one of our blog where we discusses about differing and […]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.